Patents by Inventor Daniela Melisi

Daniela Melisi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8551958
    Abstract: Pro-drugs of all non-steroidal anti-inflammatories with free acid function derivatized with an ester group, which have the general structural formula given below (I) where A is: aspirin, diflunisal, benorylate, ibufenac, diclofenac, indomethacin, sulindac, ketorolac, ibuprofen, naproxen, ketoprofen, fenoprofen, flurbiprofen, mefenamic acid, meclof enamic acid, flufenamic acid, niflumic acid, and where in the ester group R can be a sugar (amongst which aldose, or ketose pentose, or esose selected from a group of D- and L-enantioiuers of ribose, glucose, galactose, mannose, arabinose, xilose, allose, altrose, gulose, idose and talose and substituted derivatives thereof, such as glucosamine, galactosamine, N-acetyl glucosamine, N-acetyl galactosamine, N-acetyl ribosamine), a disaccharide, a trisaccharide or an oligosaccharide.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: October 8, 2013
    Assignees: Stewart Italia Srl
    Inventors: Maria Grazia Rimoli, Antonio Calignano, Rosario Cuomo, Gianpiero Boatto, Enrico Abignente, Daniela Melisi, Annalisa Curcio, Elvira Luongo, Giovanna La Rana, Oscar Sasso, Giovanni Sarnelli, Roberto Russo, Maria Nieddu, Carla Cirillo, Salvatore De Lucia
  • Publication number: 20110212904
    Abstract: Pro-drugs of all non-steroidal anti-inflammatories with free acid function derivatized with an ester group, which have the general structural formula given below (I) where A is: aspirin, diflunisal, benorylate, ibufenac, diclofenac, indomethacin, sulindac, ketorolac, ibuprofen, naproxen, ketoprofen, fenoprofen, flurbiprofen, mefenamic acid, meclof enamic acid, flufenamic acid, niflumic acid, and where in the ester group R can be a sugar (amongst which aldose, or ketose pentose, or esose selected from a group of D- and L-enantioiuers of ribose, glucose, galactose, mannose, arabinose, xilose, allose, altrose, gulose, idose and talose and substituted derivatives thereof, such as glucosamine, galactosamine, N-acetyl glucosamine, N-acetyl galactosamine, N-acetyl ribosamine), a disaccharide, a trisaccharide or an oligosaccharide.
    Type: Application
    Filed: January 28, 2011
    Publication date: September 1, 2011
    Applicants: STEWART ITALIA SRL
    Inventors: Maria Grazia RIMOLI, Antonio CALIGNANO, Rosario CUOMO, Gianpiero BOATTO, Enrico ABIGNENTE, Daniela MELISI, Annalisa CURCIO, Elvira LUONGO, Giovanna LA RANA, Oscar SASSO, Giovanni SARNELLI, Roberto RUSSO, Maria NIEDDU, Carla CIRILLO, Salvatore DE LUCIA
  • Publication number: 20090098208
    Abstract: The present invention relates to pharmaceutical compositions for the oral administration of pharmacologically active molecules, comprising a release means consisting of porous zeolite in powder form, incorporating pharmacologically active molecules inside the pores and/or on its surface, the relative use for the preparation of drugs for oral administration, in particular for the treatment of inflammatory pathologies at an intestinal level and the preparation process of these compositions.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 16, 2009
    Applicant: SASOL ITALY S.p.A.
    Inventors: Maria Grazia RIMOLI, Maria Roberta Rabaioli, Enrico Abignente, Daniela Melisi, Rosella Mirabelli, Ettore Novellino, Annalisa Curcio, Salvatore De Lucia, Alessandro Nasti